Moleculin Biotech
MBRX0.400060.78% ( -0.6200 )
Moleculin Biotech (MBRX)
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and v...
- Open
- 0.8801
- High
- 1.0690
- Low
- 0.3123
- Prev. Close
- 1.0200
- Volume
- 19.31M
- Turnover
- 9.03M
- Avg Price
- 0.4674
- Bid/Ask Ratio
- --
- Amplitude
- 74.19%
- 52wk High
- 18.2500
- Volume Ratio
- 329.43
- Turnover Ratio
- 364.97%
Moleculin Biotech Analyst Rating
View MoreForecast & Rating
Jul 31, 2026Price forecast
$21.005150.00%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article · 2 days ago, 12:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- PUBT · 2 days ago, 09:12 AM
Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price
- Tip Ranks · 2 days ago, 07:34 AM
Moleculin Biotech Highlights Promising MIRACLE Trial Remission Data
- benzinga_article · 2 days ago, 07:05 AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- PUBT · 2 days ago, 07:05 AM
Moleculin says MIRACLE trial posts 37% interim CRc rate in venetoclax-failed AML patients
- benzinga_article · Jul 29 at 12:06 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
